Europe Precision Medicine Market Size, Status and Forecast 2014-2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The Precision Medicine market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 2.5% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Precision Medicine Market Segmentations:

    By Player:

    • Illumina

    • Randox Laboratories

    • Healthcore

    • Johnson & Johnson

    • Biomrieux Sa

    • IBM

    • Roche

    • Qiagen

    • Novartis

    • Abbott Laboratories

    • Laboratory Corporation of America Holdings

    • GE Healthcare

    • Thermo Fisher Scientific

    • Cepheid

    • Intel Corporation

    • Almac Group

    By Type:

    • Diagnostics

    • Therapies

    By End-User:

    • Oncology

    • Neurosciences

    • Immunology

    • Respiratory

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Precision Medicine Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Precision Medicine Market Size and Growth Rate of Diagnostics from 2014 to 2026

    • 1.3.2 Europe Precision Medicine Market Size and Growth Rate of Therapies from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Precision Medicine Market Size and Growth Rate of Oncology from 2014 to 2026

    • 1.4.2 Europe Precision Medicine Market Size and Growth Rate of Neurosciences from 2014 to 2026

    • 1.4.3 Europe Precision Medicine Market Size and Growth Rate of Immunology from 2014 to 2026

    • 1.4.4 Europe Precision Medicine Market Size and Growth Rate of Respiratory from 2014 to 2026

    • 1.4.5 Europe Precision Medicine Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Precision Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Precision Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Precision Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Precision Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Precision Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Precision Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Precision Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Precision Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Precision Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Precision Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Precision Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Precision Medicine Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Precision Medicine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Precision Medicine by Major Types

      • 3.4.1 Market Size and Growth Rate of Diagnostics

      • 3.4.2 Market Size and Growth Rate of Therapies

    4 Segmentation of Precision Medicine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Precision Medicine by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Oncology for Construction

      • 4.4.2 Market Size and Growth Rate of Neurosciences for Construction

      • 4.4.3 Market Size and Growth Rate of Immunology for Construction

      • 4.4.4 Market Size and Growth Rate of Respiratory for Construction

      • 4.4.5 Market Size and Growth Rate of Others for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Precision Medicine Production Analysis by Top Regions

    • 5.2 Europe Precision Medicine Consumption Analysis by Top Regions

    • 5.3 Europe Precision Medicine Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Precision Medicine Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Precision Medicine Production, Import, Consumption and Export Analysis

      • 5.3.3 France Precision Medicine Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Precision Medicine Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Precision Medicine Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Precision Medicine Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Precision Medicine Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Precision Medicine Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Precision Medicine Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Precision Medicine Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Precision Medicine Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Precision Medicine Production, Import, Consumption and Export Analysis

    6 Product Circulation of Precision Medicine Market among Top Countries

    • 6.1 Top 5 Export Countries in Precision Medicine Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Precision Medicine Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Precision Medicine Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Precision Medicine Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Precision Medicine Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Precision Medicine Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Precision Medicine Landscape Analysis

    • 7.1 Germany Precision Medicine Landscape Analysis by Major Types

    • 7.2 Germany Precision Medicine Landscape Analysis by Major End-Users

    8. UK Precision Medicine Landscape Analysis

    • 8.1 UK Precision Medicine Landscape Analysis by Major Types

    • 8.2 UK Precision Medicine Landscape Analysis by Major End-Users

    9. France Precision Medicine Landscape Analysis

    • 9.1 France Precision Medicine Landscape Analysis by Major Types

    • 9.2 France Precision Medicine Landscape Analysis by Major End-Users

    10. Italy Precision Medicine Landscape Analysis

    • 10.1 Italy Precision Medicine Landscape Analysis by Major Types

    • 10.2 Italy Precision Medicine Landscape Analysis by Major End-Users

    11. Spain Precision Medicine Landscape Analysis

    • 11.1 Spain Precision Medicine Landscape Analysis by Major Types

    • 11.2 Spain Precision Medicine Landscape Analysis by Major End-Users

    12. Poland Precision Medicine Landscape Analysis

    • 12.1 Poland Precision Medicine Landscape Analysis by Major Types

    • 12.2 Poland Precision Medicine Landscape Analysis by Major End-Users

    13. Russia Precision Medicine Landscape Analysis

    • 13.1 Russia Precision Medicine Landscape Analysis by Major Types

    • 13.2 Russia Precision Medicine Landscape Analysis by Major End-Users

    14. Switzerland Precision Medicine Landscape Analysis

    • 14.1 Switzerland Precision Medicine Landscape Analysis by Major Types

    • 14.2 Switzerland Precision Medicine Landscape Analysis by Major End-Users

    15. Turkey Precision Medicine Landscape Analysis

    • 15.1 Turkey Precision Medicine Landscape Analysis by Major Types

    • 15.2 Turkey Precision Medicine Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Precision Medicine Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Precision Medicine Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Precision Medicine Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Precision Medicine Landscape Analysis by Top Countries

      • 16.3.1 Denmark Precision Medicine Market Volume and Growth Rate

      • 16.3.2 Finland Precision Medicine Market Volume and Growth Rate

      • 16.3.3 Norway Precision Medicine Market Volume and Growth Rate

      • 16.3.4 Sweden Precision Medicine Market Volume and Growth Rate

      • 16.3.6 Iceland Precision Medicine Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Precision Medicine Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Precision Medicine Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Precision Medicine Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Precision Medicine Landscape Analysis by Top Countries

      • 17.3.1 Belgium Precision Medicine Market Volume and Growth Rate

      • 17.3.2 Netherlands Precision Medicine Market Volume and Growth Rate

      • 17.3.3 Luxembourg Precision Medicine Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Precision Medicine Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Precision Medicine Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Precision Medicine Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Precision Medicine Landscape Analysis by Top Countries

      • 18.3.1 Estonia Precision Medicine Market Volume and Growth Rate

      • 18.3.2 Latvia Precision Medicine Market Volume and Growth Rate

      • 18.3.3 Lithuania Precision Medicine Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Illumina

      • 19.1.1 Illumina Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Randox Laboratories

      • 19.2.1 Randox Laboratories Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Healthcore

      • 19.3.1 Healthcore Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Johnson & Johnson

      • 19.4.1 Johnson & Johnson Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Biomrieux Sa

      • 19.5.1 Biomrieux Sa Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 IBM

      • 19.6.1 IBM Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Roche

      • 19.7.1 Roche Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Qiagen

      • 19.8.1 Qiagen Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Novartis

      • 19.9.1 Novartis Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Abbott Laboratories

      • 19.10.1 Abbott Laboratories Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Laboratory Corporation of America Holdings

      • 19.11.1 Laboratory Corporation of America Holdings Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 GE Healthcare

      • 19.12.1 GE Healthcare Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Thermo Fisher Scientific

      • 19.13.1 Thermo Fisher Scientific Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Cepheid

      • 19.14.1 Cepheid Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Intel Corporation

      • 19.15.1 Intel Corporation Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 Almac Group

      • 19.16.1 Almac Group Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    The List of Tables and Figures (Totals 80 Figures and 197 Tables)

    • Figure Product Picture

    • Figure Precision Medicine Market Size and Growth Rate of Diagnostics Market, 2015 - 2026 (USD Million)

    • Figure Precision Medicine Market Size and Growth Rate of Therapies Market, 2015 - 2026 (USD Million)

    • Figure Precision Medicine Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Precision Medicine Market Size and Growth Rate of Neurosciences from 2014 to 2026

    • Figure Precision Medicine Market Size and Growth Rate of Immunology from 2014 to 2026

    • Figure Precision Medicine Market Size and Growth Rate of Respiratory from 2014 to 2026

    • Figure Precision Medicine Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Precision Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure UK Precision Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure France Precision Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Precision Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Precision Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Precision Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Precision Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Precision Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Precision Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Precision Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Precision Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Precision Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Precision Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Precision Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Precision Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Precision Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Precision Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Precision Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Precision Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Precision Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Precision Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Precision Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Precision Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Precision Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Precision Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Precision Medicine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Precision Medicine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Precision Medicine by Different Types from 2014 to 2026

    • Table Consumption Share of Precision Medicine by Different Types from 2014 to 2026

    • Figure Precision Medicine Market Size and Growth Rate of Diagnostics Market, 2015 - 2026 (USD Million)

    • Figure Precision Medicine Market Size and Growth Rate of Therapies Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Precision Medicine by Different End-Users from 2014 to 2026

    • Table Consumption Share of Precision Medicine by Different End-Users from 2014 to 2026

    • Figure Precision Medicine Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Precision Medicine Market Size and Growth Rate of Neurosciences from 2014 to 2026

    • Figure Precision Medicine Market Size and Growth Rate of Immunology from 2014 to 2026

    • Figure Precision Medicine Market Size and Growth Rate of Respiratory from 2014 to 2026

    • Figure Precision Medicine Market Size and Growth Rate of Others from 2014 to 2026

    • Table Europe Precision Medicine Production by Major Regions

    • Table Europe Precision Medicine Production Share by Major Regions

    • Figure Europe Precision Medicine Production Share by Major Countries and Regions in 2014

    • Table Europe Precision Medicine Consumption by Major Regions

    • Table Europe Precision Medicine Consumption Share by Major Regions

    • Table Germany Precision Medicine Production, Import, Consumption and Export Analysis

    • Table UK Precision Medicine Production, Import, Consumption and Export Analysis

    • Table France Precision Medicine Production, Import, Consumption and Export Analysis

    • Table Italy Precision Medicine Production, Import, Consumption and Export Analysis

    • Table Spain Precision Medicine Production, Import, Consumption and Export Analysis

    • Table Poland Precision Medicine Production, Import, Consumption and Export Analysis

    • Table Russia Precision Medicine Production, Import, Consumption and Export Analysis

    • Table Switzerland Precision Medicine Production, Import, Consumption and Export Analysis

    • Table Turkey Precision Medicine Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Precision Medicine Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Precision Medicine Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Precision Medicine Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Precision Medicine Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Precision Medicine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Precision Medicine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Precision Medicine Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Precision Medicine Consumption by Types from 2014 to 2026

    • Table Germany Precision Medicine Consumption Share by Types from 2014 to 2026

    • Table Germany Precision Medicine Consumption by End-Users from 2014 to 2026

    • Table Germany Precision Medicine Consumption Share by End-Users from 2014 to 2026

    • Table UK Precision Medicine Consumption by Types from 2014 to 2026

    • Table UK Precision Medicine Consumption Share by Types from 2014 to 2026

    • Table UK Precision Medicine Consumption by End-Users from 2014 to 2026

    • Table UK Precision Medicine Consumption Share by End-Users from 2014 to 2026

    • Table France Precision Medicine Consumption by Types from 2014 to 2026

    • Table France Precision Medicine Consumption Share by Types from 2014 to 2026

    • Table France Precision Medicine Consumption by End-Users from 2014 to 2026

    • Table France Precision Medicine Consumption Share by End-Users from 2014 to 2026

    • Table Italy Precision Medicine Consumption by Types from 2014 to 2026

    • Table Italy Precision Medicine Consumption Share by Types from 2014 to 2026

    • Table Italy Precision Medicine Consumption by End-Users from 2014 to 2026

    • Table Italy Precision Medicine Consumption Share by End-Users from 2014 to 2026

    • Table Spain Precision Medicine Consumption by Types from 2014 to 2026

    • Table Spain Precision Medicine Consumption Share by Types from 2014 to 2026

    • Table Spain Precision Medicine Consumption by End-Users from 2014 to 2026

    • Table Spain Precision Medicine Consumption Share by End-Users from 2014 to 2026

    • Table Poland Precision Medicine Consumption by Types from 2014 to 2026

    • Table Poland Precision Medicine Consumption Share by Types from 2014 to 2026

    • Table Poland Precision Medicine Consumption by End-Users from 2014 to 2026

    • Table Poland Precision Medicine Consumption Share by End-Users from 2014 to 2026

    • Table Russia Precision Medicine Consumption by Types from 2014 to 2026

    • Table Russia Precision Medicine Consumption Share by Types from 2014 to 2026

    • Table Russia Precision Medicine Consumption by End-Users from 2014 to 2026

    • Table Russia Precision Medicine Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Precision Medicine Consumption by Types from 2014 to 2026

    • Table Switzerland Precision Medicine Consumption Share by Types from 2014 to 2026

    • Table Switzerland Precision Medicine Consumption by End-Users from 2014 to 2026

    • Table Switzerland Precision Medicine Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Precision Medicine Consumption by Types from 2014 to 2026

    • Table Turkey Precision Medicine Consumption Share by Types from 2014 to 2026

    • Table Turkey Precision Medicine Consumption by End-Users from 2014 to 2026

    • Table Turkey Precision Medicine Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Precision Medicine Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Precision Medicine Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Precision Medicine Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Precision Medicine Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Precision Medicine Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Precision Medicine Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Precision Medicine Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Precision Medicine Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Precision Medicine Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Precision Medicine Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Precision Medicine Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Precision Medicine Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Precision Medicine Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Precision Medicine Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Precision Medicine Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Precision Medicine Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Precision Medicine Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Precision Medicine Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Precision Medicine Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Precision Medicine Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Precision Medicine Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Precision Medicine Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Precision Medicine Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Precision Medicine Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Precision Medicine Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Precision Medicine Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Precision Medicine Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Precision Medicine Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Precision Medicine Market Volume and Growth Rate from 2014 to 2026

    • Table Illumina Profiles

    • Table Illumina Production, Value, Price, Gross Margin 2014-2019

    • Table Illumina Product benchmarking

    • Table Illumina Strategic initiatives

    • Table Illumina SWOT analysis

    • Table Randox Laboratories Profiles

    • Table Randox Laboratories Production, Value, Price, Gross Margin 2014-2019

    • Table Randox Laboratories Product benchmarking

    • Table Randox Laboratories Strategic initiatives

    • Table Randox Laboratories SWOT analysis

    • Table Healthcore Profiles

    • Table Healthcore Production, Value, Price, Gross Margin 2014-2019

    • Table Healthcore Product benchmarking

    • Table Healthcore Strategic initiatives

    • Table Healthcore SWOT analysis

    • Table Johnson & Johnson Profiles

    • Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019

    • Table Johnson & Johnson Product benchmarking

    • Table Johnson & Johnson Strategic initiatives

    • Table Johnson & Johnson SWOT analysis

    • Table Biomrieux Sa Profiles

    • Table Biomrieux Sa Production, Value, Price, Gross Margin 2014-2019

    • Table Biomrieux Sa Product benchmarking

    • Table Biomrieux Sa Strategic initiatives

    • Table Biomrieux Sa SWOT analysis

    • Table IBM Profiles

    • Table IBM Production, Value, Price, Gross Margin 2014-2019

    • Table IBM Product benchmarking

    • Table IBM Strategic initiatives

    • Table IBM SWOT analysis

    • Table Roche Profiles

    • Table Roche Production, Value, Price, Gross Margin 2014-2019

    • Table Roche Product benchmarking

    • Table Roche Strategic initiatives

    • Table Roche SWOT analysis

    • Table Qiagen Profiles

    • Table Qiagen Production, Value, Price, Gross Margin 2014-2019

    • Table Qiagen Product benchmarking

    • Table Qiagen Strategic initiatives

    • Table Qiagen SWOT analysis

    • Table Novartis Profiles

    • Table Novartis Production, Value, Price, Gross Margin 2014-2019

    • Table Novartis Product benchmarking

    • Table Novartis Strategic initiatives

    • Table Novartis SWOT analysis

    • Table Abbott Laboratories Profiles

    • Table Abbott Laboratories Production, Value, Price, Gross Margin 2014-2019

    • Table Abbott Laboratories Product benchmarking

    • Table Abbott Laboratories Strategic initiatives

    • Table Abbott Laboratories SWOT analysis

    • Table Laboratory Corporation of America Holdings Profiles

    • Table Laboratory Corporation of America Holdings Production, Value, Price, Gross Margin 2014-2019

    • Table Laboratory Corporation of America Holdings Product benchmarking

    • Table Laboratory Corporation of America Holdings Strategic initiatives

    • Table Laboratory Corporation of America Holdings SWOT analysis

    • Table GE Healthcare Profiles

    • Table GE Healthcare Production, Value, Price, Gross Margin 2014-2019

    • Table GE Healthcare Product benchmarking

    • Table GE Healthcare Strategic initiatives

    • Table GE Healthcare SWOT analysis

    • Table Thermo Fisher Scientific Profiles

    • Table Thermo Fisher Scientific Production, Value, Price, Gross Margin 2014-2019

    • Table Thermo Fisher Scientific Product benchmarking

    • Table Thermo Fisher Scientific Strategic initiatives

    • Table Thermo Fisher Scientific SWOT analysis

    • Table Cepheid Profiles

    • Table Cepheid Production, Value, Price, Gross Margin 2014-2019

    • Table Cepheid Product benchmarking

    • Table Cepheid Strategic initiatives

    • Table Cepheid SWOT analysis

    • Table Intel Corporation Profiles

    • Table Intel Corporation Production, Value, Price, Gross Margin 2014-2019

    • Table Intel Corporation Product benchmarking

    • Table Intel Corporation Strategic initiatives

    • Table Intel Corporation SWOT analysis

    • Table Almac Group Profiles

    • Table Almac Group Production, Value, Price, Gross Margin 2014-2019

    • Table Almac Group Product benchmarking

    • Table Almac Group Strategic initiatives

    • Table Almac Group SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.